Table of Contents Table of Contents
Previous Page  261 / 1195 Next Page
Information
Show Menu
Previous Page 261 / 1195 Next Page
Page Background

AOAC INTERNATIONAL

Secondary enrichments were struck for isolation on BGS and BS agars. Isolated presumptive

367

Salmonella

were confirmed as directed in the Health Canada Compendium guidelines

368

(biochemical, serological).

369

370

Environmental Sponges –

A dilution level previously established for the given strain/surface

371

combination to give inoculation levels appropriate for achieving fractional positive results (5-15

372

positives per trial) was used for the stainless steel surface environmental sample type. Samples

373

were applied to surfaces (100 µL of the appropriately diluted broth culture combined with ~10 X of

374

a non-target competitor strain) and allowed to dry for one day. FDA BAM samples were collected

375

by sponge hydrated with 10mL DE broth. After returning the sponge to the sample bag, samples

376

were held at 4±3°C for 2-3 hours prior to addition of 225 mL of LB. Media and sponge were swirled

377

thoroughly to mix and allowed to stand 60 ± 5 min at room temperature. Samples were again

378

mixed well by swirling and pH determined with test paper. Using 1 N HCl or NaOH, pH was

379

adjusted if necessary to 6.8 ± 0.2. Samples were incubated for 22-26 hours at 35°C. Enriched

380

samples were added in 0.1-mL aliquots to 10-mL FDA RV broth (prepared from constituent

381

components on the day of testing) and incubated for 24

±

2 hr at 42±0.2°C. An additional 1-mL

382

aliquot of each enrichment was added to 10 mL TT broth and incubated for 24

±

2 hr at 35±2°C. All

383

samples were then struck in 10-μL amounts on BS agar, XLD agar and HE agar. Agar plates were

384

incubated at 35°C for 24±2 hr after which plates were examined for colonies with typical

385

characteristics of

Salmonella

. Suspect colonies were confirmed using the biochemical and

386

serological methods described in the FDA-BAM. Additionally, for each sample, a 3 hr regrowth in

387

BHI (10μl of enriched sample added to 500μl of prewarmed BHI which was incubated at 37°C for 3

388

hrs) was performed and BAX® testing was performed on this sample as well in order to have a

389

validated protocol for samples where PCR inhibitors may be present on the sampled surfaces. All

390

samples were then struck in 10-μL amounts on BS agar, XLD agar and HE agar. Agars were

391

incubated at 35°C for 24±2 hr after which plates were examined for colonies with typical

392

characteristics of

Salmonella

. Suspect colonies were confirmed using the biochemical and

393

serological methods described in the FDA-BAM.

394

Dupont BAX Salmonella PTM Report

PTM Certification No. 081201 (08/07/2012)

For Expert Review Panel Use Only

Do Not Distribute